Colon and rectum cancer screening coverage in Europe in Portugal

Portugal: Colon and rectum cancer screening coverage in Europe was 16.1% in 2024. ▲ Rising

Latest (2024)
16.1%
Change on year
down 6.4%
World rank
18th
of 20 countries
All-time high
17.2%
in 2023
All-time low
5.9%
in 2020
Years of data
6
2019–2024

Colon and rectum cancer screening coverage in Europe in Portugal, 2019–2024

57.51012.51517.52019202120242019: 9.1 %2020: 5.9 %2021: 13.2 %2022: 13.5 %2023: 17.2 %2024: 16.1 %

Source: Eurostat (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

The most recent figure for colon and rectum cancer screening coverage in europe in Portugal is 16.1%, measured in 2024.

Compared with earlier readings it is down 6.4% on the previous year and up 76.9% over ten years.

That places Portugal 18th out of 20 countries with data for 2024, putting it in the bottom quarter.

Colon and rectum cancer screening coverage in Europe in Portugal, year by year

Annual values for Colon and rectum cancer screening coverage in Europe in Portugal, 2019 to 2024.
Year % Change
2019 9.1% —
2020 5.9% -35.2%
2021 13.2% +123.7%
2022 13.5% +2.3%
2023 17.2% +27.4%
2024 16.1% -6.4%

Portugal compared with similar countries

  • Portugal's 16.1% is below the median for Europe & Central Asia, which is 39.2%, 41% of the median. (19 countries reporting)
  • Portugal's 16.1% is below the median for high income countries, which is 46.6%, 35% of the median. (16 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 9.1% 9.1% 9.1% 1
2020s 13.2% 5.9% 17.2% 5

Countries ranked near Portugal

  1. 15 France 29.6% compare
  2. 16 Latvia 28.0% compare
  3. 17 Montenegro 22.7% compare
  4. 19 Germany 15.0%
  5. 20 Serbia 7.5% compare

See the full ranking of 20 places →

More health data for Portugal

All data for Portugal →

Frequently asked questions

What is colon and rectum cancer screening coverage in europe in Portugal?
Colon and rectum cancer screening coverage in europe in Portugal was 16.1% in 2024, according to Eurostat (2026) – with minor processing by Our World in Data.
What is the highest colon and rectum cancer screening coverage in europe recorded in Portugal?
The highest recorded value was 17.2% in 2023.
What is the lowest colon and rectum cancer screening coverage in europe recorded in Portugal?
The lowest recorded value was 5.9% in 2020.
How does Portugal rank for colon and rectum cancer screening coverage in europe?
Portugal ranks 18th out of 20 countries with data for 2024.
Is colon and rectum cancer screening coverage in europe rising or falling in Portugal?
Over the last ten years it is up 76.9%. The long-run trend across the full record is rising.
Where does this Portugal data come from?
The figures come from Eurostat (2026) – with minor processing by Our World in Data, published as part of Colon and rectum cancer screening coverage in Europe. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Colon and rectum cancer screening coverage in Europe in Portugal. Statizoid, drawing on Eurostat (2026) – with minor processing by Our World in Data. Retrieved 26 September 2026, from https://health.statizoid.com/stat/colon-and-rectum-cancer-screening-coverage-in-europe/portugal/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/colon-and-rectum-cancer-screening-coverage-in-europe/portugal/">Colon and rectum cancer screening coverage in Europe in Portugal</a> — Statizoid

About this data

Indicator
Colon and rectum cancer screening coverage in Europe
Unit
%
Source
Eurostat (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
20 places, 209 data points, 2008–2025
Last refreshed

Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.